Security key
451033708
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO)
CUSIP: 451033708
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 8
- Total 13F value
- $5
- Share change
- 0
- SEC-reported price per share
- $0.62
- Number of holders
- 1
- Shares outstanding
- 64,277,140
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
1
Top holders
1
IBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
iBio, Inc. SEC filings
iBio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 451033708
Recent filing periods:
Ownership snapshot
Top reported holders of IBIO - iBio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F
3/4/5
Highest disclosed value: $1,093,340
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $1.09M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$1.09M
VANGUARD GROUP INC
$1.08M
BlackRock Finance, Inc.
$286.9K
Bank of New York Mellon Corp
$183.2K
GEODE CAPITAL MANAGEMENT, LLC
$158.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$1,093,340
525,644 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,080,083
519,271 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$286,906
137,936 shares
|
— | 31 Mar 2023 |
| Bank of New York Mellon Corp |
13F
Company
|
—
denominator unverified
|
$183,156
88,056 shares
|
— | 31 Mar 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$158,672
76,285 shares
|
— | 31 Mar 2023 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$153,078
73,595 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
8
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q2 2026 Across Filers
Q2 2026 holders
55
Q2 2023 holders
1
Holder diff
-54
| Investor | Q2 2026 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend